small molecule

ZINGO

LIDOCAINE HYDROCHLORIDE

Loss of exclusivitySeptember 2035latest FDA-listed patent expiry

CompanyPowder →See this company's full patent-cliff portfolio

Drug detail

Brand name	ZINGO
Active ingredient	LIDOCAINE HYDROCHLORIDE
Strength	0.5MG
Dosage form	SYSTEM
Route	INTRADERMAL
Modality	Small molecule
FDA approval	August 2007
Marketing status	DISCN

Listed patents

Patent	Expires	Type
9370622	September 2035	use U-1870
9358338	April 2035	use U-1870
8540665	October 2029	use U-1438

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.